KLRS
VOYA Investment Management’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-21,504
| Closed | -$14.6K | – | 2900 |
|
2023
Q4 | $14.6K | Hold |
21,504
| – | – | ﹤0.01% | 2895 |
|
2023
Q3 | $46.2K | Buy |
21,504
+4,432
| +26% | +$9.53K | ﹤0.01% | 2862 |
|
2023
Q2 | $58K | Buy |
17,072
+4,226
| +33% | +$14.4K | ﹤0.01% | 2887 |
|
2023
Q1 | $50.6K | Hold |
12,846
| – | – | ﹤0.01% | 2800 |
|
2022
Q4 | $65.9K | Hold |
12,846
| – | – | ﹤0.01% | 2817 |
|
2022
Q3 | $101K | Buy |
12,846
+1,467
| +13% | +$11.6K | ﹤0.01% | 2776 |
|
2022
Q2 | $44K | Hold |
11,379
| – | – | ﹤0.01% | 2755 |
|
2022
Q1 | $77K | Hold |
11,379
| – | – | ﹤0.01% | 2551 |
|
2021
Q4 | $147K | Sell |
11,379
-258
| -2% | -$3.33K | ﹤0.01% | 2593 |
|
2021
Q3 | $292K | Sell |
11,637
-497
| -4% | -$12.5K | ﹤0.01% | 2359 |
|
2021
Q2 | $240K | Sell |
12,134
-624
| -5% | -$12.3K | ﹤0.01% | 2498 |
|
2021
Q1 | $299K | Buy |
12,758
+5,000
| +64% | +$117K | ﹤0.01% | 2317 |
|
2020
Q4 | $298K | Buy |
+7,758
| New | +$298K | ﹤0.01% | 2200 |
|